cholangiocarcinoma - Robuta Search

https://www.elsevier.es/en-revista-annals-hepatology-16-estadisticas-clinical-treatment-cholangiocarcinoma-an-updated-S1665268122000795 Clinical treatment of cholangiocarcinoma: an updated comprehensive review | Annals of Hepatology clinical treatment comprehensive review cholangiocarcinoma updated annals https://ascopost.com/news/october-2021/ivosidenib-vs-placebo-for-previously-treated-advanced-idh1-mutated-cholangiocarcinoma-final-overall-survival-analysis-of-the-claridhy-trial/ Ivosidenib vs Placebo for Previously Treated Advanced IDH1-Mutated Cholangiocarcinoma Final Overall... As reported in JAMA Oncology by Andrew X. Zhu, MD, PhD, and colleagues, the final overall survival analysis of the pivotal phase III ClarIDHy trial showed... vs placebo previously treated advanced https://boa.unimib.it/handle/10281/143410 Autocrine and paracrine mechanisms promoting chemoresistance in cholangiocarcinoma autocrine paracrine mechanisms promoting cholangiocarcinoma https://www.humpath.com/spip.php?article23337 combined hepatocellular-cholangiocarcinoma - Humpath.com - Human pathology Combined hepatocellular-cholangiocarcinoma (CHC) is a rare tumor with poor prognosis, with incidence ranging from 1.0%-4.7% of all primary (...) human pathology combined cholangiocarcinoma https://iris.unito.it/handle/2318/1941031 Cholangiocarcinoma tumor microenvironment highlighting fibrosis and matrix components tumor microenvironment cholangiocarcinoma highlighting fibrosis matrix https://veri.larvol.com/associations/pten-mutation+msi-h-dmmr_cholangiocarcinoma_pd1-inhibitor Cholangiocarcinoma - PD1 inhibitor - PTEN mutation + MSI-H/dMMR - LARVOL VERI LARVOL VERI predictive biomarker evidence connecting Cholangiocarcinoma, PD1 inhibitor, and PTEN mutation + MSI-H/dMMR. cholangiocarcinoma inhibitor pten mutation msi https://ecancer.org/en/video/8302-comment-targeted-therapy-ivosidenib-in-cholangiocarcinoma Comment: Targeted therapy ivosidenib in cholangiocarcinoma - ecancer Dr Angela Lamarca comments on data from the ClarIDHy trial during a press conference at the 2019 ESMO congress. This was a phase III trial evaluating th targeted therapy comment cholangiocarcinoma https://www.politesi.polimi.it/handle/10589/208379 Characterization and validation of a 3D Cholangiocarcinoma-on-chip model as a reliable in vitro... in vitro characterization validation cholangiocarcinoma chip https://iris.uniroma4.it/handle/20.500.14244/4400 Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling... the camp secretin inhibits cholangiocarcinoma growth https://www.alliedacademies.org/articles/staging-and-management-process-of-cholangiocarcinoma-24085.html Staging and management process of cholangiocarcinoma A holistic approach to prognostication, treatment classification and outcome comparison is best provided by staging systems. However, none of the CCA staging... management process staging cholangiocarcinoma https://pure.ewha.ac.kr/en/publications/long-term-prognosis-of-combined-hepatocellular-and-cholangiocarci/ Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection... long term prognosis combined cholangiocarcinoma curative https://pubmed.ncbi.nlm.nih.gov/37167366/ Pulmonary Embolism Detected by Bone Scintigraphy in a Patient With Intrahepatic Cholangiocarcinoma A 99m Tc-DPD bone scintigraphy with SPECT/CT was performed in a 64-year-old woman with intrahepatic cholangiocarcinoma to exclude osseous metastases. The... pulmonary embolism detected bone patient cholangiocarcinoma https://bibliographie.uni-tuebingen.de/xmlui/handle/10900/128482?show=full Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations promotion cholangiocarcinoma growth diverse cancer https://etheses.whiterose.ac.uk/id/eprint/27914/ Developing novel targeted diagnostics and therapeutics for cholangiocarcinoma - White Rose eTheses... white rose developing novel targeted diagnostics https://pure.johnshopkins.edu/en/publications/mir-21-targets-15-pgdh-and-promotes-cholangiocarcinoma-growth-2/ miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth - Johns Hopkins University johns hopkins university mir targets cholangiocarcinoma growth https://pure.fujita-hu.ac.jp/en/publications/prognostic-impact-of-inflammation-based-scores-for-extrahepatic-c/ Prognostic Impact of Inflammation-Based Scores for Extrahepatic Cholangiocarcinoma - Fujita Health... impact inflammation based scores cholangiocarcinoma https://www.cleverlysmart.com/bile-duct-cancer-cholangiocarcinoma-causes-symptoms-and-treatment/?noamp=mobile Bile Duct Cancer (Cholangiocarcinoma): Symptoms, Treatment Jul 19, 2023 - Cholangiocarcinoma or bile duct cancer is a malignant tumor developed from the intra or extra hepatic bile ducts or the gallbladder. bile duct cancer cholangiocarcinoma symptoms treatment https://iris.uniupo.it/handle/11579/199331 Lymphoid infiltrate predicts prognosis of mass-forming intrahepatic cholangiocarcinoma undergoing... infiltrate predicts prognosis mass forming https://www.testmycholangio.com/ Get Your Cholangiocarcinoma (CCA) Tested for Biomarkers get cholangiocarcinoma cca tested biomarkers https://www.clinicaltrialsarena.com/projects/tibsovo-ivosidenib-indicated-relapsed-refractory-acute-myeloid-leukaemia/ TIBSOVO for Relapsed/Refractory AML and Cholangiocarcinoma, US Jul 6, 2022 - TIBSOVO (ivosidenib) is the first approved targeted therapy for patients with IDH1-mutated advanced cholangiocarcinoma. refractory aml cholangiocarcinoma us https://www.cholangiocarcinoma-eu.com/ Cholangiocarcinoma iCCA Cholangiocarcinoma, also known as bile duct cancer or biliary tract cancer, is a type of cancer that originates in the bile duct cholangiocarcinoma icca https://research.unipd.it/handle/11577/3465164 Impact of Positive Radial Margin on Recurrence and Survival in Perihilar Cholangiocarcinoma impact positive radial margin recurrence https://checkorphan.org/clinicaltrial/intra-hepatic-chemotherapy-in-patient-with-non-resectable-liver-metastases-from-cholangiocarcinoma/ Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma... liver metastases intra hepatic chemotherapy patient https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-orphan-drug-designation-to-certepetide-in-cholangiocarcinoma/ FDA Grants Orphan Drug Designation to Certepetide in Cholangiocarcinoma FDA Grants Orphan Drug Designation to Certepetide in Cholangiocarcinoma fda grants orphan drug designation https://www.observerxtra.com/what-is-cholangiocarcinoma-and-how-is-it-treated/ What is cholangiocarcinoma and how is it treated? what is cholangiocarcinoma treated https://researchexperts.utmb.edu/en/publications/radiotherapy-in-the-treatment-of-patients-with-unresectable-extra/fingerprints/ Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma -... the treatment radiotherapy patients cholangiocarcinoma https://gi.org/tag/cholangiocarcinoma/ cholangiocarcinoma Archives - American College of Gastroenterology american college cholangiocarcinoma archives gastroenterology https://www.spandidos-publications.com/or/22/3/649 Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: Prognostic impact Oncology Reports is an international journal devoted to fundamental and applied research in Oncology. expression cholangiocarcinoma impact https://scholar.xjtu.edu.cn/zh/publications/programmed-death-ligand-1-expression-in-human-intrahepatic-cholan/ Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma and its association... programmed death ligand expression human https://www.uclahealth.org/cancer/cancer-services/gi-cancer/conditions/bile-duct-cancer Bile Duct Cancer - Cholangiocarcinoma - Gastrointestinal Cancer | UCLA Health Jonsson Comprehensive... Bile duct cancer (cholangiocarcinoma) and gallbladder cancer are rare, related tumors. Learn more here, or request an appointment at UCLA Health. bile duct cancer ucla health cholangiocarcinoma gastrointestinal jonsson https://journal.waocp.org/article_90550.html Molecular Targets and Signaling Pathways in Cholangiocarcinoma: A Systematic Review Background: Cholangiocarcinoma (CCA) is the second most frequent hepatobiliary cancer after hepatocellular carcinoma with a poor prognosis and limited... a systematic review molecular targets signaling pathways cholangiocarcinoma https://easl.eu/publication/intrahepatic-cholangiocarcinoma-global-increase-in-mortality/ Intrahepatic cholangiocarcinoma global increase in mortality - EASL-The Home of Hepatology. the home cholangiocarcinoma global increase mortality https://www.oaepublish.com/articles/2394-5079.2021.130 Epidemiology of cholangiocarcinoma Aim: We aimed to analyze temporal trends in mortality from intrahepatic (ICC) and extrahepatic (ECC) cholangiocarcinoma in selected countries... epidemiology cholangiocarcinoma https://www.cancer.gov/types/liver/bile-duct-cancer What Is Bile Duct Cancer (Cholangiocarcinoma)? - NCI Bile duct cancer (cholangiocarcinoma) is cancer that forms in the bile ducts. Learn more about the types of bile duct cancer and bile duct cancer symptoms. bile duct cancer what is cholangiocarcinoma nci https://pure.lib.cgu.edu.tw/en/publications/characterization-of-intrahepatic-cholangiocarcinoma-of-the-intrad/ Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its... characterization cholangiocarcinoma growth type https://scienmag.com/tag/intrahepatic-cholangiocarcinoma-treatment-resistance/ intrahepatic cholangiocarcinoma treatment resistance | Science cholangiocarcinoma treatment resistance science https://iris.hunimed.eu/handle/11699/8860 Combined hepatocellular carcinoma - cholangiocarcinoma harboring a metastasis of colon... hepatocellular carcinoma combined cholangiocarcinoma metastasis colon https://iris.unisr.it/handle/20.500.11768/94104 Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma following... management outcomes patients recurrent cholangiocarcinoma https://unifind.uniss.it/resource/item/103154?language=en-US Curative Resection for Hilar Cholangiocarcinoma: Single-Center Experience with Long-Term Follow-Up... Unifind is a portal where you can discover the expertise within a university by searching among experts, courses, professions, people, publications, and... single center long term follow up curative cholangiocarcinoma https://profiles.ncat.edu/en/publications/reflection-on-a-case-of-cholangiocarcinoma-view-from-the-patient--4/ Reflection on a case of Cholangiocarcinoma; View from the Patient Side - N.C. A&T Scholars on a from the reflection case cholangiocarcinoma https://www.apollohospitals.com/book-doctor-appointment/bile-duct-cancer-cholangiocarcinoma/treatment/bhopal Best Cholangiocarcinoma (Bile Duct Cancer) Doctors in Bhopal | Book Appointment | Apollo Hospitals bile duct cancer book appointment apollo hospitals best cholangiocarcinoma https://bpno.no/medtalks/pemigatinib-for-previously-treated-locally-advanced-metastatic-cholangiocarcinoma/ Pemigatinib for previously treated locally advanced/metastatic cholangiocarcinoma Jul 26, 2024 - Pemigatinib - a oral FGFR1-3 inhibitor has shown efficacy and safety in patients with advanced/metastatic cholangiocarcinoma publish in the Lancet Oncol 2020.... previously treated locally advanced metastatic https://publications.rwth-aachen.de/record/852317 The prognostic value of neutrophil-to-lymphocyte ratio in cholangiocarcinoma : a systematic review... Liu, Dong; Heij, Lara; Czigany, Zoltan; Dahl, Edgar; Den Dulk, Marcel; Lang, Sven; Ulmer, Tom Florian; Neumann, Ulf Peter; Bednarsch, Jan a systematic review value lymphocyte ratio cholangiocarcinoma